Barclays
CLMT icon

Barclays’s Calumet Specialty Products CLMT Stock Holding History

Barclays’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,800
Closed -$7K – 5634
2020
Q1 		$7K Buy
6,800
+5,800
+580% +$19.6K ﹤0.01% 5887
2019
Q4 		$4K Sell
1,000
-400
-29% -$1.38K ﹤0.01% 6186
2019
Q3 		$5K Sell
1,400
-400
-22% -$1.71K ﹤0.01% 6438
2019
Q2 		$8K Sell
1,800
-12,900
-88% -$51.6K ﹤0.01% 6601
2019
Q1 		$52K Buy
14,700
+11,500
+359% +$38.2K ﹤0.01% 5836
2018
Q4 		$7K Sell
3,200
-5,200
-62% -$21.4K ﹤0.01% 6315
2018
Q3 		$54K Buy
8,400
+800
+11% +$5.68K ﹤0.01% 6030
2018
Q2 		$57K Sell
7,600
-11,900
-61% -$89.4K ﹤0.01% 5578
2018
Q1 		$137K Sell
19,500
-102,000
-84% -$754K ﹤0.01% 5147
2017
Q4 		$936K Sell
121,500
-50,900
-30% -$424K ﹤0.01% 3179
2017
Q3 		$1.44M Buy
172,400
+170,300
+8,110% +$1.06M ﹤0.01% 2656
2017
Q2 		$9K Sell
2,100
-3,800
-64% -$15.2K ﹤0.01% 6074
2017
Q1 		$22K Buy
5,900
+1,200
+26% +$4.75K ﹤0.01% 5759
2016
Q4 		$19K Buy
4,700
+600
+15% +$2.45K ﹤0.01% 5642
2016
Q3 		$18K Sell
4,100
-800
-16% -$4.12K ﹤0.01% 5524
2016
Q2 		$24K Sell
4,900
-2,100
-30% -$11.9K ﹤0.01% 5198
2016
Q1 		$77K Buy
7,000
+6,900
+6,900% +$96K ﹤0.01% 4523
2015
Q4 		$2K Sell
100
-9,200
-99% -$227K ﹤0.01% 5740
2015
Q3 		$223K Buy
9,300
+2,200
+31% +$57.2K ﹤0.01% 4065
2015
Q2 		$178K Sell
7,100
-5,000
-41% -$133K ﹤0.01% 4218
2015
Q1 		$290K Sell
12,100
-1,900
-14% -$48.1K ﹤0.01% 4066
2014
Q4 		$308K Buy
14,000
+5,200
+59% +$135K ﹤0.01% 4280
2014
Q3 		$238K Sell
8,800
-12,800
-59% -$387K ﹤0.01% 4586
2014
Q2 		$670K Buy
21,600
+15,400
+248% +$458K ﹤0.01% 3703
2014
Q1 		$155K Buy
6,200
+5,300
+589% +$145K ﹤0.01% 5041
2013
Q4 		$23K Sell
900
-100
-10% -$2.79K ﹤0.01% 6623
2013
Q3 		$27K Sell
1,000
-8,500
-89% -$267K ﹤0.01% 6384
2013
Q2 		$346K Buy
+9,500
New +$342K ﹤0.01% 4639

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Barclays's CLMT Position: Q1 2026 in Review

Barclays increased its Calumet Specialty Products (CLMT) stake by 300% in Q1 2026, buying an estimated $13.2M and bringing the position to 677,913 shares worth $24.3M. The position accounts for 0.01% of the portfolio, ranked #1014.

Barclays first reported a position in CLMT in Q2 2013 and has held it in 48 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Barclays held 677,913 shares of Calumet Specialty Products worth $24.3M as of Q1 2026.
  • Barclays bought 508,423 Calumet Specialty Products shares in Q1 2026, an estimated $13.2M.
  • Calumet Specialty Products made up 0.01% of Barclays's portfolio in Q1 2026, its #1014 holding.
  • Barclays first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 48 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.